SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-081568
Filing Date
2024-07-03
Accepted
2024-07-03 16:30:03
Documents
3
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 PRE 14A apvo-2024-pre14a_-_june_.htm PRE 14A 336913
2 GRAPHIC img83661039_0.jpg GRAPHIC 501262
3 GRAPHIC img83661039_1.jpg GRAPHIC 381543
  Complete submission text file 0000950170-24-081568.txt   1552959
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37746 | Film No.: 241100463
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)